Financials in GBp. Standardized financial statements.
A compact view of how LungLife AI, Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Revenue? | £46,000 | £24,000 | £195,566 | £205,180 | £136,492 | £982,019 |
| Revenue Growth? | +91.7% | -87.7% | -4.7% | +50.3% | -86.1% | 0.0% |
| Cost of Revenue? | £0 | £0 | £96,269 | £188,178 | £149,890 | £73,481 |
| Gross Profit? | £46,000 | £24,000 | £99,297 | £17,000 | -£13,398 | £908,538 |
| Gross Margin? | +100.0% | +100.0% | +50.8% | +8.3% | -9.8% | +92.5% |
| Operating Expenses? | £5.68M | £7.66M | £5.44M | £4.08M | £3.40M | £3.16M |
| Operating Income? | -£5.63M | -£7.64M | -£5.34M | -£4.06M | -£3.41M | -£2.26M |
| EBITDA? | -£5.11M | -£7.26M | -£6.69M | -£3.78M | -£3.11M | -£1.93M |
| Income Before Tax | -£5.41M | -£7.60M | -£7.43M | -£4.84M | -£3.97M | -£2.57M |
| Income Tax Expense | £7,000 | £4,000 | £15,872 | £777,186 | £765,494 | £2,753 |
| Net Income? | -£5.41M | -£7.61M | -£7.44M | -£5.62M | -£4.74M | -£3.25M |
| EPS? | £-0.21 | £-0.30 | £-0.47 | £-0.22 | £-0.19 | £-0.13 |
| Diluted EPS? | £-0.21 | £-0.30 | £-0.47 | £-0.22 | £-0.19 | £-0.13 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality